PAOLA SALGUERO: Open Payments
NPI 1992380091 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 80 payments from 16 companies in 2025. Trend: 2023 $3,075 · 2024 $2,176 · 2025 $1,735
Food & beverage: $1,735
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 12 | $300 |
| Novartis Pharmaceuticals Corporation | 15 | $228 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $185 |
| Amgen Inc. | 11 | $183 |
| Boston Scientific Corporation | 3 | $142 |
| Alnylam Pharmaceuticals Inc. | 5 | $119 |
| PFIZER INC. | 4 | $99 |
| BridgeBio Pharma, Inc. | 4 | $97 |
| Esperion Therapeutics, Inc. | 4 | $90 |
| Kestra Medical Technology Services, Inc. | 1 | $55 |
Products named: Barostim Neo System, LEQVIO, JARDIANCE, REPATHA, Attruby, FARAPULSE, NEXLETOL, ONPATTRO.
Industry payments across FL — which companies pay providers there.
